Traders cheered Aurobindo's in-line performance by sending the stock nearly 4 percent higher. But they punished Sun Pharma for missing Street estimates across the board by sending the stock down over 6 percent. CNBC-TV18's Ekta Batra and Archana Shukla crunch the numbers.
first published: May 31, 2016 09:54 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty fails to defend 25,100, breaks 4-day surge | Closing Bell
Live: Can bulls continue to defend Nifty's 25,100 zone? | Opening Bell
Live: Nifty holds gain for 4th day, above 25,100 on weekly expiry day | Closing bell
Zoho CEO Mani Vembu On Why India Needs Arattai, Growth Surge And Integrating Businesses | Exclusive
